Chelsea gains after droxidopa data

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) jumped $0.51 (20%) to $3.02 on Thursday after

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE